NEUROENDOCRINE CANCER

Clinical trials for NEUROENDOCRINE CANCER explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CANCER trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Completed 1

New combo therapy shows promise for rare gut and lung cancers

Disease control Completed

This phase 2 trial tested a combination of two drugs—pembrolizumab (Keytruda) and lenvatinib (Lenvima)—in 20 people with advanced neuroendocrine tumors that had worsened despite prior treatments. The goal was to see if the combination could shrink tumors or slow disease progressi…

Matched conditions: NEUROENDOCRINE CANCER

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

NEUROENDOCRINE CANCER

Get alerted when new NEUROENDOCRINE CANCER trials appear

New combo therapy shows promise for rare gut and lung cancers